Please login to the form below
AirFluSal
This page shows the latest AirFluSal news and features for those working in and with pharma, biotech and healthcare.
Vectura's Flutiform flunks phase III COPD test
But new AirFluSal data demonstrates superior patient adherence over GSK’s Seretide/Advair. ... GSK's product is delivered using its long-established Diskus device, while AirFluSal uses the Vectura-developed Forspiro.
Latest news
-
Teva's Symbicort generic backed for EU approval
The Advair generic, called AirFluSal Forspiro, has since been given a green light in Germany and Sweden.
More from news
Approximately 1 fully matching, plus 1 partially matching documents found.
Subscribe to our email news alerts
- OPEN Health and Nested Knowledge announce strategic research collaboration to leverage AI technologies for evidence synthesis
- FDA approves two cell-based gene therapies for sickle cell disease
- Pfizer’s Elrexfio granted EC approval for relapsed and refractory multiple myeloma
- New economic data reveals risk of disincentivising UK life sciences growth
- WHO countries hold seventh INB meeting to prevent global pandemics
- The start of a beautiful friendship
No results were found
PMHub
Graphite Digital
We’re a digital CX agency collaborating with healthcare and pharmaceutical organisations to help them connect more deeply with their audiences...
Latest intelligence
- Virtual care – negotiating barriers to adoption offers glimpses of an exciting future
- Digital tools and innovative healthcare promise to address pressing healthcare issues if they can satisfy concerns over access, security and affordability...
- Clinical Trials Investigator and Patient Engagement Planning: A Customer Story
- ...
- New Playbook Alert: Virtual Patient Engagement
- ...
